Ancora Pharmaceuticals' Unattributed VC - II Round

Ancora Pharmaceuticals raised a round of funding on May 16, 2008. Investors include Harris & Harris Group.

Ancora Pharmaceuticals aims to enable synthetic carbohydrate-based product discovery and development utilizing its carbohydrate synthesis capability, which is based on technology originally developed …

Articles about Ancora Pharmaceuticals' Unattributed VC - II Round: